デフォルト表紙
市場調査レポート
商品コード
1586178

細胞解離市場:製品タイプ、組織、エンドユーザー別-2025-2030年の世界予測

Cell Dissociation Market by Product (Enzymatic Dissociation Products, Instruments & Accessories, Non-Enzymatic Dissociation Products), Type (Cell Detachment, Tissue Dissociation), Tissue, End-User - Global Forecast 2025-2030


出版日
発行
360iResearch
ページ情報
英文 192 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.30円
細胞解離市場:製品タイプ、組織、エンドユーザー別-2025-2030年の世界予測
出版日: 2024年10月31日
発行: 360iResearch
ページ情報: 英文 192 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

細胞解離市場は、2023年に7億5,932万米ドルと評価され、2024年には8億7,860万米ドルに達すると予測され、CAGR 16.91%で成長し、2030年には22億6,764万米ドルに達すると予測されています。

細胞解離とは、組織や培養物から細胞を遊離させるプロセスを指し、一般的には酵素的、化学的、機械的手法によって達成されます。この手順は、アッセイ用の細胞調製、シングルセルRNAシーケンス、幹細胞研究、治療開発など、様々なアプリケーションに不可欠です。細胞解離の必要性は、研究者や臨床医が隔離された環境で細胞の挙動や機能を研究することを可能にする役割にあり、これにより細胞生物学の理解が著しく深まり、実験結果の精度が向上します。最終用途の範囲は学術研究、製薬、バイオテクノロジー業界に及び、特に再生医療やがん研究における利用拡大が顕著です。

主な市場の統計
基準年[2023] 7億5,932万米ドル
予測年[2024] 8億7,860万米ドル
予測年[2030] 22億6,764万米ドル
CAGR(%) 16.91%

細胞解離市場は、バイオテクノロジーの進歩、精密医療への注目の高まり、高度な治療介入を必要とする慢性疾患の有病率の上昇など、いくつかの成長要因に後押しされています。細胞に優しい非酵素的解離法の開発や、効率と再現性を高める自動化プロセスの統合に新たな機会が存在します。このような機会を生かすための主な提言としては、革新的な解離技術の研究開発への投資や、最先端の細胞生物学研究に注力する機関との戦略的提携が挙げられます。

しかしながら、この市場は、高度な解離技術に関連する高コスト、規制上の課題、細胞の生存率や機能性に影響を及ぼす可能性のある特定の解離技術によって引き起こされる潜在的な細胞損傷などの制約に直面しています。各社がこうしたハードルを克服しようと努力する中で、解離後の細胞生存率を向上させるための調査や、細胞ストレスを最小限に抑えるための技術の改良に重点が置かれることが、技術革新の可能性のある分野です。

市場力学はダイナミックであり、急速な技術進歩や、研究活動における持続可能性や倫理的配慮の重視の高まりを特徴としています。規制状況を乗り切り、費用対効果の高いソリューションに焦点を当てながら、これらの分野に対応するために戦略を調整する企業は、この進化する市場で競争力を獲得する立場にあります。

市場力学:急速に進化する細胞解離市場における主要市場インサイトの解明

細胞解離市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

  • 市場促進要因
    • 製薬・バイオ医薬品企業における細胞ベースの研究活動の普及拡大
    • 慢性疾患や感染症の罹患率と罹患率の上昇
    • 幹細胞研究活動に対する政府からの資金提供の有無
  • 市場抑制要因
    • 組織や細胞を用いた治療法の高コスト
  • 市場機会
    • 先進的な細胞解離製品の継続的な導入
    • 細胞解離開発に対する規制当局の承認増加
  • 市場の課題
    • 低開発国における細胞ベースの研究のための限られたインフラストラクチャー

ポーターの5つの力:細胞解離市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、細胞解離市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析:細胞解離市場における外部からの影響の把握

外部マクロ環境要因は、細胞解離市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析細胞解離市場における競合情勢の把握

細胞解離市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的な意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス細胞解離市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、細胞解離市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨細胞解離市場における成功への道筋を描く

細胞解離市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています:

1.市場の浸透度:現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度:新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化:最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報:競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション:将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています:

1.現在の市場規模と今後の成長予測は?

2.最高の投資機会を提供する製品、セグメント、地域はどこか?

3.市場を形成する主な技術動向と規制の影響とは?

4.主要ベンダーの市場シェアと競合ポジションは?

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 製薬企業やバイオ医薬品企業における細胞ベースの調査活動の普及が拡大
      • 慢性疾患および感染症の発生率と有病率の上昇
      • 幹細胞調査活動に対する政府資金の利用可能性
    • 抑制要因
      • 組織および細胞に基づく処置の高コスト
    • 機会
      • 先進的な細胞解離製品の継続的なイントロダクション
      • 細胞解離開発に対する規制当局の承認の増加
    • 課題
      • 発展途上国における細胞調査のためのインフラの不足
  • 市場セグメンテーション分析
  • ポーターのファイブフォース分析
  • PESTEL分析
    • 政治的
    • 経済
    • 社交
    • 技術的
    • 法律上
    • 環境

第6章 細胞解離市場:製品別

  • 酵素分解製品
    • コラーゲナーゼ
    • DNアーゼ
    • エラスターゼ
    • ヒアルロニダーゼ
    • パパイン
    • トリプシン
  • 楽器とアクセサリー
  • 非酵素分解生成物

第7章 細胞解離市場:タイプ別

  • 細胞の剥離
  • 組織解離

第8章 細胞解離市場ティッシュ

  • 結合組織
  • 上皮組織
  • 骨格と筋肉組織

第9章 細胞解離市場:エンドユーザー別

  • 製薬・バイオテクノロジー企業
  • 調査と学術

第10章 南北アメリカの細胞解離市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第11章 アジア太平洋地域の細胞解離市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第12章 欧州・中東・アフリカの細胞解離市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第13章 競合情勢

  • 市場シェア分析2023
  • FPNVポジショニングマトリックス, 2023
  • 競合シナリオ分析
    • アジレント、電子捕獲解離技術を手掛ける企業の買収を発表
    • S2 Genomics、スカンジナビア地域へのサービス提供のためTechtum Lab ABとの販売契約を締結
    • アプライドセルズ、次世代細胞分離ソリューションで使用する試薬キットに関してステムセルテクノロジーズと供給契約を締結
    • LevitasBioがLeviPrepとLeviSelect製品ラインを発表
  • 戦略分析と提言

企業一覧

  • Abeomics Inc.
  • AcceGen
  • ACROBiosystems Group
  • ALSTEM
  • AMS Biotechnology
  • Becton, Dickinson and Company
  • Bio-Techne Corporation
  • Biogenuix Medsystems Pvt. Ltd.
  • Capricorn Scientific
  • Captivate Bio, LLC
  • Cell Signaling Technology, Inc.
  • Cellseco Ltd.
  • Cellsystems Gmbh
  • Celprogen Corporation
  • Central Drug House.(P)Ltd.
  • Corning Inc.
  • Creative Bioarray
  • Cytori Therapeutics Inc.
  • Diagnocine
  • F. Hoffmann-La Roche Ltd.
  • FlowMetric, Inc.
  • Gemini BioProducts LLC
  • Genaxxon bioscience GmbH
  • Genlantis Inc.
  • Genomics, Inc.
  • HiMedia Laboratories Private Limited
  • Innovative Cell Technologies, Inc.
  • Krackeler Scientific, Inc.
  • Merck KGaA
  • Miltenyi Biotec B.V. & Co. KG
  • MP Biomedicals, LLC
  • Nacalai Tesque, Inc.
  • Neuromics
  • Nordmark Pharma GmbH
  • PAN-Biotech GmbH
  • PELOBIOTECH GmbH
  • PromoCell GmbH
  • Protein Ark Ltd. by CalibreScientific
  • REPROCELL Inc.
  • RWD Life Science Co., Ltd.
  • Sartorius AG
  • ScienCell Research Laboratories, Inc.
  • Singleron Biotechnologies GmbH
  • STEMCELL Group
  • Stemmera Inc.
  • Tebubio
  • Thermo Fisher Scientific Inc.
  • VitaCyte, LLC
  • VWR International, LLC
  • Worthington Biochemical Corporation
図表

LIST OF FIGURES

  • FIGURE 1. CELL DISSOCIATION MARKET RESEARCH PROCESS
  • FIGURE 2. CELL DISSOCIATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CELL DISSOCIATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CELL DISSOCIATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CELL DISSOCIATION MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CELL DISSOCIATION MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CELL DISSOCIATION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CELL DISSOCIATION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. CELL DISSOCIATION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. CELL DISSOCIATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CELL DISSOCIATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CELL DISSOCIATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CELL DISSOCIATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CELL DISSOCIATION MARKET DYNAMICS
  • TABLE 7. GLOBAL CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CELL DISSOCIATION MARKET SIZE, BY COLLAGENASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CELL DISSOCIATION MARKET SIZE, BY DNASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CELL DISSOCIATION MARKET SIZE, BY ELASTASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CELL DISSOCIATION MARKET SIZE, BY HYALURONIDASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CELL DISSOCIATION MARKET SIZE, BY PAPAIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CELL DISSOCIATION MARKET SIZE, BY TRYPSIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CELL DISSOCIATION MARKET SIZE, BY INSTRUMENTS & ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CELL DISSOCIATION MARKET SIZE, BY NON-ENZYMATIC DISSOCIATION PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CELL DISSOCIATION MARKET SIZE, BY CELL DETACHMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CELL DISSOCIATION MARKET SIZE, BY TISSUE DISSOCIATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CELL DISSOCIATION MARKET SIZE, BY CONNECTIVE TISSUES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CELL DISSOCIATION MARKET SIZE, BY EPITHELIAL TISSUES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CELL DISSOCIATION MARKET SIZE, BY SKELETAL & MUSCLES TISSUES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CELL DISSOCIATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CELL DISSOCIATION MARKET SIZE, BY RESEARCH & ACADEMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES CELL DISSOCIATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA CELL DISSOCIATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM CELL DISSOCIATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM CELL DISSOCIATION MARKET SIZE, BY ENZYMATIC DISSOCIATION PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM CELL DISSOCIATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM CELL DISSOCIATION MARKET SIZE, BY TISSUE, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM CELL DISSOCIATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 237. CELL DISSOCIATION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 238. CELL DISSOCIATION MARKET, FPNV POSITIONING MATRIX, 2023
目次
Product Code: MRR-46132FF79DDC

The Cell Dissociation Market was valued at USD 759.32 million in 2023, expected to reach USD 878.60 million in 2024, and is projected to grow at a CAGR of 16.91%, to USD 2,267.64 million by 2030.

Cell dissociation refers to the process of releasing cells from tissues or cultures, typically achieved through enzymatic, chemical, or mechanical methods. This procedure is crucial for various applications, including cell preparation for assays, single-cell RNA sequencing, stem cell research, and therapeutic developments. The necessity of cell dissociation lies in its role in enabling researchers and clinicians to study cellular behaviors and functions in isolated environments, which significantly enhances the understanding of cellular biology and improves the accuracy of experimental outcomes. The end-use scope spans academic research, pharmaceutical and biotechnology industries, with expanding use in regenerative medicine and cancer research being particularly notable.

KEY MARKET STATISTICS
Base Year [2023] USD 759.32 million
Estimated Year [2024] USD 878.60 million
Forecast Year [2030] USD 2,267.64 million
CAGR (%) 16.91%

The market for cell dissociation is propelled by several growth factors, including advancements in biotechnology, the increasing focus on precision medicine, and the rising prevalence of chronic diseases that necessitate advanced therapeutic interventions. Emerging opportunities exist in the development of non-enzymatic dissociation methods that are gentler on cells and the integration of automated processes to increase efficiency and reproducibility. Key recommendations to exploit these opportunities include investment in R&D for innovative dissociation technologies and strategic partnerships with institutions focusing on cutting-edge cell biology research.

However, the market faces limitations such as high costs associated with advanced dissociation technologies, regulatory challenges, and potential cell damage caused by certain dissociation techniques that can affect cell viability and functionality. As companies strive to overcome these hurdles, emphasis on research to improve cell viability post-dissociation and the refinement of techniques to minimize cell stress are potential areas of innovation.

The cell dissociation market is dynamic, characterized by rapid technological advancements and a growing emphasis on sustainability and ethical considerations in research practices. Companies that align their strategies to address these areas while navigating regulatory landscapes and focusing on cost-effective solutions stand to gain a competitive edge in this evolving market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cell Dissociation Market

The Cell Dissociation Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing prevalence of cell based research activities across pharmaceutical and biopharmaceutical companies
    • Rising incidence and prevalence of chronic and infectious diseases
    • Availability of government funding for stem-cell research activities
  • Market Restraints
    • High cost of tissue and cell based procedures
  • Market Opportunities
    • Ongoing introduction of advanced cell dissociation products
    • Rising regulatory approvals for the cell dissociation developments
  • Market Challenges
    • Limited infrastructure for the cell-based research in underdeveloped countries

Porter's Five Forces: A Strategic Tool for Navigating the Cell Dissociation Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cell Dissociation Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cell Dissociation Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cell Dissociation Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cell Dissociation Market

A detailed market share analysis in the Cell Dissociation Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cell Dissociation Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cell Dissociation Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cell Dissociation Market

A strategic analysis of the Cell Dissociation Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cell Dissociation Market, highlighting leading vendors and their innovative profiles. These include Abeomics Inc., AcceGen, ACROBiosystems Group, ALSTEM, AMS Biotechnology, Becton, Dickinson and Company, Bio-Techne Corporation, Biogenuix Medsystems Pvt. Ltd., Capricorn Scientific, Captivate Bio, LLC, Cell Signaling Technology, Inc., Cellseco Ltd., Cellsystems Gmbh, Celprogen Corporation, Central Drug House. (P) Ltd., Corning Inc., Creative Bioarray, Cytori Therapeutics Inc., Diagnocine, F. Hoffmann-La Roche Ltd., FlowMetric, Inc., Gemini BioProducts LLC, Genaxxon bioscience GmbH, Genlantis Inc., Genomics, Inc., HiMedia Laboratories Private Limited, Innovative Cell Technologies, Inc., Krackeler Scientific, Inc., Merck KGaA, Miltenyi Biotec B.V. & Co. KG, MP Biomedicals, LLC, Nacalai Tesque, Inc., Neuromics, Nordmark Pharma GmbH, PAN-Biotech GmbH, PELOBIOTECH GmbH, PromoCell GmbH, Protein Ark Ltd. by CalibreScientific, REPROCELL Inc., RWD Life Science Co., Ltd., Sartorius AG, ScienCell Research Laboratories, Inc., Singleron Biotechnologies GmbH, STEMCELL Group, Stemmera Inc., Tebubio, Thermo Fisher Scientific Inc., VitaCyte, LLC, VWR International, LLC, and Worthington Biochemical Corporation.

Market Segmentation & Coverage

This research report categorizes the Cell Dissociation Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Enzymatic Dissociation Products, Instruments & Accessories, and Non-Enzymatic Dissociation Products. The Enzymatic Dissociation Products is further studied across Collagenase, DNase, Elastase, Hyaluronidase, Papain, and Trypsin.
  • Based on Type, market is studied across Cell Detachment and Tissue Dissociation.
  • Based on Tissue, market is studied across Connective Tissues, Epithelial Tissues, and Skeletal & Muscles Tissues.
  • Based on End-User, market is studied across Pharmaceutical & Biotechnology Companies and Research & Academics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of cell based research activities across pharmaceutical and biopharmaceutical companies
      • 5.1.1.2. Rising incidence and prevalence of chronic and infectious diseases
      • 5.1.1.3. Availability of government funding for stem-cell research activities
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of tissue and cell based procedures
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing introduction of advanced cell dissociation products
      • 5.1.3.2. Rising regulatory approvals for the cell dissociation developments
    • 5.1.4. Challenges
      • 5.1.4.1. Limited infrastructure for the cell-based research in underdeveloped countries
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cell Dissociation Market, by Product

  • 6.1. Introduction
  • 6.2. Enzymatic Dissociation Products
    • 6.2.1. Collagenase
    • 6.2.2. DNase
    • 6.2.3. Elastase
    • 6.2.4. Hyaluronidase
    • 6.2.5. Papain
    • 6.2.6. Trypsin
  • 6.3. Instruments & Accessories
  • 6.4. Non-Enzymatic Dissociation Products

7. Cell Dissociation Market, by Type

  • 7.1. Introduction
  • 7.2. Cell Detachment
  • 7.3. Tissue Dissociation

8. Cell Dissociation Market, by Tissue

  • 8.1. Introduction
  • 8.2. Connective Tissues
  • 8.3. Epithelial Tissues
  • 8.4. Skeletal & Muscles Tissues

9. Cell Dissociation Market, by End-User

  • 9.1. Introduction
  • 9.2. Pharmaceutical & Biotechnology Companies
  • 9.3. Research & Academics

10. Americas Cell Dissociation Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Cell Dissociation Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Cell Dissociation Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Agilent Announces Acquisition of Company Behind Electron Capture Dissociation Technology
    • 13.3.2. S2 Genomics Announces Distribution Agreement with Techtum Lab AB to Serve Scandinavia
    • 13.3.3. Applied Cells Enters into a Supply Agreement with STEMCELL Technologies on Reagent Kits for Use in a Next-Generation Solution for Cell Separation
    • 13.3.4. LevitasBio Unveils LeviPrep and LeviSelect Product Lines
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abeomics Inc.
  • 2. AcceGen
  • 3. ACROBiosystems Group
  • 4. ALSTEM
  • 5. AMS Biotechnology
  • 6. Becton, Dickinson and Company
  • 7. Bio-Techne Corporation
  • 8. Biogenuix Medsystems Pvt. Ltd.
  • 9. Capricorn Scientific
  • 10. Captivate Bio, LLC
  • 11. Cell Signaling Technology, Inc.
  • 12. Cellseco Ltd.
  • 13. Cellsystems Gmbh
  • 14. Celprogen Corporation
  • 15. Central Drug House. (P) Ltd.
  • 16. Corning Inc.
  • 17. Creative Bioarray
  • 18. Cytori Therapeutics Inc.
  • 19. Diagnocine
  • 20. F. Hoffmann-La Roche Ltd.
  • 21. FlowMetric, Inc.
  • 22. Gemini BioProducts LLC
  • 23. Genaxxon bioscience GmbH
  • 24. Genlantis Inc.
  • 25. Genomics, Inc.
  • 26. HiMedia Laboratories Private Limited
  • 27. Innovative Cell Technologies, Inc.
  • 28. Krackeler Scientific, Inc.
  • 29. Merck KGaA
  • 30. Miltenyi Biotec B.V. & Co. KG
  • 31. MP Biomedicals, LLC
  • 32. Nacalai Tesque, Inc.
  • 33. Neuromics
  • 34. Nordmark Pharma GmbH
  • 35. PAN-Biotech GmbH
  • 36. PELOBIOTECH GmbH
  • 37. PromoCell GmbH
  • 38. Protein Ark Ltd. by CalibreScientific
  • 39. REPROCELL Inc.
  • 40. RWD Life Science Co., Ltd.
  • 41. Sartorius AG
  • 42. ScienCell Research Laboratories, Inc.
  • 43. Singleron Biotechnologies GmbH
  • 44. STEMCELL Group
  • 45. Stemmera Inc.
  • 46. Tebubio
  • 47. Thermo Fisher Scientific Inc.
  • 48. VitaCyte, LLC
  • 49. VWR International, LLC
  • 50. Worthington Biochemical Corporation